Announced
Completed
Hypera completed the acquisition of Buscopan brand from Boehringer Ingelheim for $319m.
Synopsis
Hypera, Brazilian pharmaceutical company, completed the acquisition of Buscopan brand from Boehringer Ingelheim, the second largest animal health business in the world, for $319m.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite